Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Post by lovingstocks23on Sep 20, 2018 12:40pm
83 Views
Post# 28656529

Strong buy in my book

Strong buy in my bookEveryone calm the f down. 
If any of you remember, last year we were among the last to surge to 3$. 
Everyone else starting jumping to new highs around Dec 17, and we started around Dec 28. 

Strongest points of THC Biomed: 

1) Provincial supply agreements - guaranteed revenue of at least $12M (average $6/gram multiplied by confirmed 2,000,000 grams for province of BC) 

2) GMP Certification - significantly easier access to international purchase orders i.e. Germany exports 

3) Highest quality of organic dried cannabis and clones - quality>quantity anytime 

4) Product reviews and product availability on the rise - please refer to Lyft reviews 

5) THC Kiss - cannabis beverages are the future, the market for beverages is exponentially larger than smoking, the goverment pledged to legalize edibles later in 2019 and once that happens, I am expecting THC to reach 10$ per share

I just want to remind you that you need have faith in your research. The same research you do, will be done by analysts managing investor portfolios and the interest in THC Biomed will only grow following Oct. 17 

Feel free to share comments and thoughts. 
Bullboard Posts